We can compound GLP-1 medications during the shortage
Semaglutide & Tirzepatide
GLP-1 Medications (Semaglutide/Tirzepatide) Resources
High Quality, Fast Turnaround GLP-1 Injections During the FDA Shortage
Compounded Semaglutide & Tirzepatide – Patient Video Instructions
It’s easy to prescribe GLP-1 medications
with
Town & Country Compounding
It’s easy to prescribe GLP-1 medications
with
Town & Country Compounding
Semaglutide
Semaglutide primarily stimulates the GLP-1 receptor, leading to increased insulin release, reduced glucagon secretion, slowed gastric emptying, and increased feelings of fullness, and it is used to improve blood sugar control and, in higher doses, for weight management.
*Activation of the GLP-1 receptor leads to several beneficial effects with both semaglutide and tirzepatide
- Increased insulin release
- Reduced glucagon secretion
- Slowed gastric emptying and increased feelings of fullness
- Decreased hunger through satiety pathways
- Up-modulates fat utilization
- Reduced ghrelin levels in the stomach/gut
Tirzepatide
Tirzepatide has a dual mechanism of action through the GLP-1 and GIP receptor agonist. Its dual action makes it distinct from medications like semaglutide, which primarily target the GLP-1 receptor alone.
Potential benefits of tirzepatide with dual receptor agonist action:
- additional weight loss benefits
- additional blood sugar control
*Activation of the GIP receptor (Glucose Dependent Insulinotropic Polypeptide, also known as Gastric Inhibiting Polypeptide)
- If used alone: Increases glucagon secretion — risky for T2D but when used in combination with a GLP-1R, down regulates glucagon levels.
- In combo with GLP-1R: enhances appetite suppression and improves WAT (white adipose tissue) health and storage capacity, thereby reducing lipid ‘spillover’ and ectopic fat accumulation (around organs: heart, liver, kidneys, etc).